Capital Fund Management (CFM)
ARCT icon

Capital Fund Management (CFM)’s Arcturus Therapeutics ARCT Stock Holding History

Capital Fund Management (CFM)’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-60,881
Closed -$958K – 1403
2022
Q2 		$958K Buy
60,881
+25,955
+74% +$509K 0.01% 1088
2022
Q1 		$942K Buy
+34,926
New +$891K 0.01% 1168

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Capital Fund Management (CFM)'s ARCT Position: Q3 2022 in Review

Capital Fund Management (CFM) sold out of Arcturus Therapeutics (ARCT) in Q3 2022, closing a stake of 60,881 shares — an estimated $958K sold.

Capital Fund Management (CFM) first reported a position in ARCT in Q1 2022 and held it in 2 quarters. The position peaked at $958K in Q2 2022. 116 funds tracked by Wall St. Rank hold ARCT as of Q3 2022.

  • Capital Fund Management (CFM) reported no remaining Arcturus Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 60,881 Arcturus Therapeutics shares in Q3 2022, an estimated $958K.
  • Capital Fund Management (CFM) first reported a position in Arcturus Therapeutics in Q1 2022 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s Arcturus Therapeutics position peaked at $958K in Q2 2022.
  • 116 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2022, filed 14 Nov 2022.